Saudi Arabia to build first foot-and-mouth disease vaccine manufacturing plant in Riyadh
The official ceremony took place on Monday and was endorsed by the Saudi Ministry of Environment, Water and Agriculture and hosted by Abdulrahman Al-Fadley, president of the Saudi Food and Drug Authority.
FMD is a contagious virus among livestock animals that can affect humans, and the new agreement aims to help Saudi Arabia become the first Arab country to be rid of the disease.
The new manufacturing facility will be built in three phases and is due to be completed within four years. Once it starts operation, it will create more than 400 job opportunities and will have the capacity to produce 200 million vaccines doses per year, Dr. Esteban Turic, CEO of Bioegénesis Bagó, told Arab News, adding that the agreement was part of its expansion plans.
“We are considering additional facilities for new animal vaccines needed in the country and wider region,” he said.
Biogénesis Bágo has more than 80 years of experience in biotechnical development and manufacturing and was selected to partner on the project after it successfully helped to eradicate FMD in Latin America and Asia. The company is a supplier for the FMD bank in the US and Canada.
“Biogénesis Bagó has current operations in KSA and the wider region. We are exporting from our main site in Argentina, from where we supply the US antigen and vaccine bank, seven countries in Latin America and four in Asia,” Turic said.
Nawaf Al-Ibrahim, CEO of MAS Company, stated that this project is part of a reforms program as part of Vision 2030 that aims to make the Kingdom self-sufficient and sustainable in food security. ■